United States 3D Printed Organ Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global 3D printed organ market reached US$ 2.41 billion in 2023 and is expected to reach US$ 6.18 billion by 2031, growing at a CAGR of 12.6% during the forecast period 2024-2031.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/3d-printed-organ-market?sb

Key Development:

United States: Recent 3D Printed Organ Developments

✅ In December 2025, researchers at St. Paul's Hospital's Centre for Heart Lung Innovation developed living human heart tissue using a custom 3D printer from patient‐derived stem cells, advancing drug testing models and laying groundwork toward complex organ bioprinting.

✅ In November 2025, a Missouri University of Science and Technology research team unveiled a light‐based 3D printing method to speed creation of organs‐on‐a‐chip - miniaturized tissue devices for drug testing and biomedical research.

✅ In November 2025, a Missouri S&T organ‐on‐a‐chip printable tissue innovation was highlighted for overcoming microcapillary printing challenges, setting a path toward faster functional tissue fabrication for medical research.

✅ In October 2025, CTIBIOTECH entered a strategic alliance with SATT AxLR and CILCARE to develop 3D bioprinted inner ear organoids from human iPSCs to enhance pharmacological screening for hearing disorders.

Japan: Recent 3D Printed Organ Developments

✅ In September 2025, Japan's healthcare 3D printing market was reported expanding rapidly with increasing integration of bioprinting tech into regenerative medicine and drug‐testing applications, reflecting private and public commitment to advanced medical manufacturing.

✅ In September 2025, recent industry context highlights Japan's broader healthcare 3D printing expansion toward personalized medical models and regenerative solutions - signaling future organ bioprinting progress.

✅ In September 2025, while no specific 3D printed organ launch occurred, Japanese research centers continue collaborations and pilot projects for functional tissue fabrication and regenerative medicine applications.

✅ In September 2025, Japan continues to strengthen its 3D bioprinting infrastructure, with ongoing R&D in organ printing and regenerative medicine to support future clinical and commercial breakthroughs.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=3d-printed-organ-market

Key Players:

=> CELLINK, Organovo Holdings Inc., CYFUSE BIOMEDICAL K.K., 3D Systems, Inc., Stratasys, United Therapeutics Corporation, Prellis Biologics, CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd. and Materialise among others.

Key Segments:

By Organ Type

Heart - ~20% share

High demand in regenerative medicine and tissue engineering due to cardiovascular disease prevalence.

Liver - ~15% share

Growing applications in drug testing, disease modeling, and transplant research.

Kidney - ~15% share

Increasing adoption for chronic kidney disease research and organ replacement studies.

Lung - ~10% share

Emerging applications in respiratory disease modeling and drug development.

Skin - ~25% share

Widely used in wound healing, cosmetic testing, and pharmaceutical applications.

Bone - ~15% share

Used in orthopedics, implant research, and tissue regeneration studies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/3d-printed-organ-market?sb

By Technology

Extrusion-Based 3D Printing - ~35% share

Most widely adopted due to versatility, cost-effectiveness, and ability to print multiple biomaterials.

Laser-Assisted Printing - ~20% share

High precision technology suitable for complex tissue structures.

Inkjet Printing - ~25% share

Popular for drug discovery, tissue scaffolding, and high-resolution models.

Magnetic Levitation - ~20% share

Emerging technology enabling scaffold-free tissue formation and regenerative applications.

By Application

Tissue Engineering - ~30% share

Leading segment driven by organ repair, scaffold development, and regenerative solutions.

Regenerative Medicine - ~25% share

High growth segment due to rising prevalence of chronic diseases and organ failure.

Drug Discovery - ~25% share

Increasing adoption for high-throughput testing and preclinical studies.

Surgical Planning - ~20% share

Growing use for preoperative simulations and personalized surgical interventions.

By End-User

Hospitals and Clinics - ~30% share

Largest segment leveraging 3D-printed tissues for patient-specific surgical planning and regenerative therapies.

Research Institutes and Laboratories - ~30% share

Significant adoption for tissue modeling, drug testing, and experimental studies.

Pharmaceutical Companies - ~25% share

Using 3D printing for drug discovery, testing, and disease modeling.

Academic Institutions - ~15% share

Focused on R&D, teaching, and proof-of-concept studies in tissue engineering and regenerative medicine.

By Region

North America - ~40% share

Dominates due to advanced healthcare infrastructure, funding, and high adoption of 3D bioprinting technologies.

Europe - ~25% share

Strong presence in tissue engineering research, regenerative medicine, and pharmaceuticals.

Asia-Pacific - ~20% share

Rapid growth driven by medical research, government support, and increasing healthcare investments.

South America - ~10% share

Growing adoption in academic research and clinical applications.

Middle East & Africa - ~5% share

Emerging market with increasing awareness and investment in advanced medical technologies.

FAQ

What is the current size of the 3D printed organ Market?

A: In 2023, the 3D printed organ Market was valued at US$ 2.41 billion, reflecting its strong industry presence.

Q2: How large is the 3D printed organ Market expected to be by 2031?

A: By 2031, industry forecasts suggest the 3D printed organ Market will grow to around US$ 6.18 billion , demonstrating significant expansion.

Q3: What is the growth rate of the 3D printed organ Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.6% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.